The NP/PA Institute
← Ground Truth
№02

Ground Truth · A brief

The Writer Behind the Script

When a script is credited to someone else, the clinician who wrote it disappears from your data.

Every commercial decision downstream of targeting (the call plan, incentive comp, the ROI read) assumes the data knows who wrote the prescription. For much of advanced practice, that assumption is shakier than it looks.

How the writer goes missing

It happens in ordinary ways. An NP or PA writes under a practice arrangement, and the prescription surfaces in commercial data under the supervising or collaborating physician. An EMR is set up with a default prescriber. A practice-level identifier stands in for the individual. In visit data, Medicare’s incident-to rules let an NP’s or PA’s services be billed under the physician’s number.

None of this is fraud or carelessness. It’s how the systems were built, and they were built before advanced practice carried the volume it carries now.

What the brand sees instead

The picture distorts in both directions. The physician looks more productive than he is and draws more attention than the business warrants. The NP or PA who actually writes looks light, lands in a low decile and gets little or none. Spend follows the credit, not the writer.

Why it compounds

Attribution error doesn’t stay in the targeting file. It flows into segmentation, field deployment and measurement. A campaign that reached the real writer can look like it failed, because the scripts she wrote were credited to someone who never saw the message.

Getting the credit right

The fix starts at the NPI level: read prescribing, diagnoses and practice relationships together, and credit each script to the clinician most likely to have written it. It’s unglamorous work. It’s also the difference between a plan built on who writes and a plan built on whose name the system happened to record.

For discussion

  1. Does our data vendor re-attribute NP and PA prescribing, and how?
  2. Which of our top-decile physicians practice alongside high-volume NPs or PAs?
  3. Are we measuring impact on the clinician we reached, or on the one who got the credit?